Projects per year
Organization profile
Organization profile
The Division of Arthritis and Rheumatic Diseases at Oregon Health & Science University is a group of academic physicians, allied health professionals and nurse practitioners specializing in the diagnosis and treatment of the full spectrum of rheumatic disorders.
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Ankylosing Spondylitis
Medicine & Life Sciences
Psoriatic Arthritis
Medicine & Life Sciences
Rheumatoid Arthritis
Medicine & Life Sciences
Placebos
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Tumor Necrosis Factor-alpha
Medicine & Life Sciences
Inflammation
Medicine & Life Sciences
T-Lymphocytes
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1978 2019
Regeneration of hyaline cartilage in situ with bone marrow mesenchymal stem cells
Chu, C.
1/1/16 → 12/31/19
Project: Research project › Non-HHS Research Projects
Hyaline Cartilage
Mesenchymal Stromal Cells
Cartilage
Regeneration
Bone Marrow
Gene Expression Profiling in Granulomatosis with Polyangiitis and Related Conditions: Insights into Pathogenesis and Nonspecific Cases
Sibley, C.
Project: Research project
Positive and Negative Regulation of IL-17 in Experimental Arthritis
Chu, C.
6/1/08 → 5/31/12
Project: Research project › Clinical Investigator Award (CIA)
Experimental Arthritis
Interleukin-17
Interferons
Th17 Cells
Arthritis
Research Output 1991 2019
2
Citations
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
Deodhar, A. A., Gensler, L. S., Sieper, J., Clark, M., Calderon, C., Wang, Y., Zhou, Y., Leu, J. H., Campbell, K., Sweet, K., Harrison, D. D., Hsia, E. C. & van der Heijde, D., Jan 1 2019, (Accepted/In press) In : Arthritis and Rheumatology.Research output: Contribution to journal › Article
Placebos
Safety
Tumor Necrosis Factor-alpha
Ustekinumab
1
Citations
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
Van Der Heijde, D., Deodhar, A. A., Fitzgerald, O., Fleischmann, R., Gladman, D., Gottlieb, A. B., Hoepken, B., Bauer, L., Irvin-Sellers, O., Khraishi, M., Peterson, L., Turkiewicz, A., Wollenhaupt, J. & Mease, P. J., Jan 1 2018, In : RMD Open. 4, 1, e000582.Research output: Contribution to journal › Article
Psoriatic Arthritis
Randomized Controlled Trials
Placebos
Safety
Psoriasis
Advances in spondyloarthritis: Glimpse in the future
Deodhar, A. A., Jul 1 2018, In : Current Opinion in Rheumatology. 30, 4, p. 301-302 2 p.Research output: Contribution to journal › Editorial